India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation

The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions

Biocon appoints Karthik SM as Head HR for India, Malaysia and Emerging Markets

In his new role, Karthik will lead human capital strategy and HR operations across these regions

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck

Microbot Medical begins full US market release of LIBERTY endovascular robotic system

Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology

Bisleri expands CSR support for rural mental health programme in MP

Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district

Vir Biotechnology advances VIR-5500 into expansion trials in prostate cancer

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals

FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review

The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis

Merck India, MAHE launch catalyst program to build future R&D talent pipeline

MoU aims to strengthen academia-industry collaboration in healthcare research and innovation